Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | n/a | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | n/a | n/a |
Pr/Book | 15.5 |
Latest | F'cast | |
---|---|---|
Revenue | n/a | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-17 | 0.36 | (4.84) | (3.21)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-18 | n/a | (7.24) | (4.46)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-19 | 0.03 | (11.14) | (4.36)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-20 | n/a | (2.93) | (0.99)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | n/a | (5.87) | (1.83)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-22 | n/a | (6.10) | (1.81)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-23 | n/a | (4.16) | (1.19)p | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2023 FactSet Research Systems Inc. All rights reserved.
Futura Remuneration, Options & Total Voting Rights | 12-Jan-2023 | 11:09 | RNS |
TR-1: Notification of major holdings | 15-Dec-2022 | 15:01 | RNS |
Futura Medical announce milestone year for MED3000 | 13-Dec-2022 | 07:00 | RNS |
Futura's looking brighter after product approval | 28-Nov-2008 | The Scotsman |
Condom breakthrough | 10-Aug-2007 | The Scotsman |
Shares go all floppy | 15-May-2007 | Sun |
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
11-Jan-23 | Placing | Andrew Vaughan Unitt | 36.36p | 26,526 | £9,644.85 |
11-Jan-23 | Placing | Jeff Needham | 36.36p | 16,344 | £5,942.68 |
11-Jan-23 | Placing | John M Clarke | 36.36p | 44,560 | £16,202.02 |
Currency | UK Pounds |
Share Price | 52.90p |
Change Today | 0.70p |
% Change | 1.34 % |
52 Week High | 56.50 |
52 Week Low | 24.70 |
Volume | 202,164 |
Shares Issued | 288.13m |
Market Cap | £152.42m |
RiskGrade | 479 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
Strong Buy | 1 |
Buy | 0 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
Time | Volume / Share Price |
10:44 | 1,438 @ 52.90p |
09:44 | 20,000 @ 52.08p |
09:27 | 3,000 @ 52.84p |
09:21 | 120 @ 52.06p |
09:16 | 10,000 @ 53.00p |
CEO | James Henry Barder |
Finance Director | Angela Hildreth |
You are here: research